Idorsia (IDRSF) Projected to Post Quarterly Earnings on Thursday

Idorsia (OTCMKTS:IDRSF) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect Idorsia to post earnings of ($0.62) per share and revenue of $19.82 million for the quarter.

Idorsia Price Performance

OTCMKTS:IDRSF opened at $0.75 on Wednesday. The firm has a 50 day simple moving average of $0.86 and a 200-day simple moving average of $1.53. Idorsia has a 1-year low of $0.70 and a 1-year high of $2.88.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.